RESEARCH

The Wang Group is engaged in the discovery and development of new catalytic reactions for efficient, sustainable organic synthesis. Research activities in the group focus on the development of novel catalysts, reagents, and conditions for the construction of challenging bonds and stereocenters found in products of interest to pharmaceutical and materials research.

These efforts have included the development of a new mode of catalytic C–H functionalization that leverages the enhanced acidity of molecules containing C–C multiple bonds upon π-coordination to cationic metal centers. The acidity enhancement allows for deprotonation and subsequent functionalization under mild conditions, enabling the redox-neutral and selective functionalization of substrates ranging from simple hydrocarbons (pKa ~ 30 to 45) to derivatives of pharmaceutically active compounds:

We have discovered that a range of cationic metal centers—ranging from base metals to precious metals and late transition metals to main group "poor metals"—can engage in this mode of deprotonative C–H bond cleavage and organometallic intermediate formation. Our program is focused on uncovering, understanding, and exploiting the differences in reactivity and selectivity resulting from varying the choice of metal and the ancillary ligand set attached thereto. We expect particular choices of metal/ligand to provide opportunities for stereocontrolled synthesis, polar/radical crossover reactivity, and the development of dual catalytic systems using a second transition metal catalyst.

periodic table